Evidence map›Paper›PMID 31533242›Full record

ArticleMetabolites2019

R-MetaboList 2: A Flexible Tool for Metabolite Annotation from High-Resolution Data-Independent Acquisition Mass Spectrometry Analysis.

Manuel D Peris-Díaz, Shannon R Sweeney, Olga Rodak, Enrique Sentandreu, Stefano Tiziani

Abstract read
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Software tools, databases and resources in metabolomics: updates from 2018 to 2019.Metabolomics : Official journal of the Metabolomic Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manuel D Peris-DíazDepartment of Chemical Biology, Faculty of Biotechnology, University of Wrocław, J.Curie 14a, 50-383 Wrocław, Poland. manuel.perisdiaz@uwr.edu.pl.
Shannon R SweeneyDell Pediatric Research Institute (DPRI), University of Texas at Austin, Austin, TX 78723, USA. ssweeney@utexas.edu.
Olga RodakDepartment of Reproduction and Clinic of Farm Animals, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, 50-366 Wrocław, Poland. olga.rodak@upwr.edu.pl.
Enrique SentandreuUnidad Analítica, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain. infusoriosentandreu@gmail.com.ORCID 0000-0002-4157-580X
Stefano TizianiDell Pediatric Research Institute (DPRI), University of Texas at Austin, Austin, TX 78723, USA. tiziani@austin.utexas.edu.ORCID 0000-0002-7230-0307

Funding

Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.R01CA189623 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI DIGIOVANNI, JOHN, GEORGIOU, GEORGE GEORGIOU · 2014 to 2018
$2.9M
Cancer Prevention and Research Institute of Texas CPRIT RP180309National Science Center of Poland 2018/31/N/ST4/01909NCI NIH HHS R01 CA189623NIH HHS CA206210-R01, CA189623
6 · The paper itself

Abstract

Technological advancements have permitted the development of innovative multiplexing strategies for data independent acquisition (DIA) mass spectrometry (MS). Software solutions and extensive compound libraries facilitate the efficient analysis of MS

Indexed as

all ion fragmentationdata-independent acquisitionfull-scan MS/MS processingliquid chromatography high-resolution mass spectrometrymetabolomicsR-MetaboList 2R programmingtargeted analysisuntargeted analysis

Identifiers

PMID31533242
PMCPMC6780920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.